(untitled)Masahiro Matsubara(Lawrence Berkeley National Laboratory)OncotargetMay 31, 201610.18632/oncotarget.v7i22Cited by 29SaveCiteExport RISWatch citationsRelated PapersInhibitors of Rho kinase (ROCK) signaling revert the malignant phenotype of breast cancer cells in 3D context|Oncotarget|2016|61